1. Home
  2. NERV vs PMI Comparison

NERV vs PMI Comparison

Compare NERV & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$5.23

Market Cap

228.5M

Sector

Health Care

ML Signal

HOLD

PMI

Picard Medical Inc.

N/A

Current Price

$0.96

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NERV
PMI
Founded
2007
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.5M
202.7M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
NERV
PMI
Price
$5.23
$0.96
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
332.2K
156.4K
Earning Date
05-12-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,175,600.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$0.92
52 Week High
$12.46
$13.68

Technical Indicators

Market Signals
Indicator
NERV
PMI
Relative Strength Index (RSI) 34.08 39.95
Support Level $5.02 N/A
Resistance Level $6.69 $1.37
Average True Range (ATR) 0.60 0.09
MACD -0.26 0.01
Stochastic Oscillator 6.54 17.17

Price Performance

Historical Comparison
NERV
PMI

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

Share on Social Networks: